Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,996,650
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
78,803,713
-
Shares change
-
+17,603,439
-
Total reported value, excl. options
-
$941,011,552
-
Value change
-
+$208,122,003
-
Put/Call ratio
-
77%
-
Number of buys
-
98
-
Number of sells
-
-46
-
Price
-
$11.94
Significant Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q2 2023
167 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - COMMON STOCK as of Q2 2023.
Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78,803,713 shares
of 101,996,650 outstanding shares and own 77% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7,809,852 shares), Atlas Venture Life Science Advisors, LLC (7,608,394 shares), FMR LLC (7,559,903 shares), VANGUARD GROUP INC (4,283,664 shares), FRANKLIN RESOURCES INC (4,065,668 shares), BlackRock Inc. (3,564,733 shares), BRAIDWELL LP (3,361,813 shares), STATE STREET CORP (3,354,326 shares), VIKING GLOBAL INVESTORS LP (2,558,563 shares), and Canaan Partners XI LLC (2,548,403 shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.